ChemotherapyAlopeciaMultimodalityTherapyDoseDenseTherapyHormoneReplacementTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriplePositiveBreastCancerCo-survivorSelf-examinationWomen ages40+ shouldhave a clinicalbreast examat least yearlyBiopsyER+NeoplasmmTORInhibitorsEGFR(epidermalgrowth factorreceptor)For every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Tyrosine-KinaseInhibitorGuaranteedRenewableInsuranceHerceptinMultifocalTumorsMetastasisPARPInhibitorsTripleNegativeBreastCancerMethotrexateNeoadjuvantTherapyAromataseInhibitorsAdvocacyACChemotherapyHER-2NodePositiveFlowCytometryBrachytherapyAntiemeticPhyllodesTumorDoxorubicinRaloxifeneIntraductalPapillomaMRILCISIn-situCarcinomaBilateralProphylacticMastectomyPathologicResponseAyurvedaSERMGeneticPredispositionLapatinibGenomicTestingGailModelLumpectomyExcisionalBiopsyGeneticCounselingMorpheaNodeNegativeCyclophosphamideStagingFISHDocetaxelCytostaticEstrogenGeneMutationPI3KinaseInhibitorsOvarianSuppressionTamoxifenRelapseRADImmunotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPagetDiseaseCachexiaKappaEpsilonAbsoluteRiskAdenocarcinomaMegestrolAcetateAxillarySamplingEstradiolAnastrozoleChemopreventionDimplingFamilyHistoryLumpMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDefinitiveSurgeryECOGScorePhysicalactivity mayreduce therisk of breastcancersDown-StagingBRCAGenePrecisionMedicinePaclitaxelInvasiveBreastCancerRadiotherapyBreastTomosynthesisCalcificationsCytotoxicBreastCancerMastectomyOligometastasesBOCAApoptosisBI-RADSLymphNodeStatusBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PalpationBevacizumabER-TumorGradeFibroadenomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMastodyniaPalbociclibHormoneReceptorStatusCDK4/6InhibitorsAntibodyTherapyCMFChemotherapyCystWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.GermlineMutationKi-67RateCapecitabine5-FluorouracilAdjuvantTherapyLymphoscintigraphyCAM1 in 8womenAngiogenesisCheckpointInhibitorProgestinChemotherapyAlopeciaMultimodalityTherapyDoseDenseTherapyHormoneReplacementTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriplePositiveBreastCancerCo-survivorSelf-examinationWomen ages40+ shouldhave a clinicalbreast examat least yearlyBiopsyER+NeoplasmmTORInhibitorsEGFR(epidermalgrowth factorreceptor)For every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Tyrosine-KinaseInhibitorGuaranteedRenewableInsuranceHerceptinMultifocalTumorsMetastasisPARPInhibitorsTripleNegativeBreastCancerMethotrexateNeoadjuvantTherapyAromataseInhibitorsAdvocacyACChemotherapyHER-2NodePositiveFlowCytometryBrachytherapyAntiemeticPhyllodesTumorDoxorubicinRaloxifeneIntraductalPapillomaMRILCISIn-situCarcinomaBilateralProphylacticMastectomyPathologicResponseAyurvedaSERMGeneticPredispositionLapatinibGenomicTestingGailModelLumpectomyExcisionalBiopsyGeneticCounselingMorpheaNodeNegativeCyclophosphamideStagingFISHDocetaxelCytostaticEstrogenGeneMutationPI3KinaseInhibitorsOvarianSuppressionTamoxifenRelapseRADImmunotherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPagetDiseaseCachexiaKappaEpsilonAbsoluteRiskAdenocarcinomaMegestrolAcetateAxillarySamplingEstradiolAnastrozoleChemopreventionDimplingFamilyHistoryLumpMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltDefinitiveSurgeryECOGScorePhysicalactivity mayreduce therisk of breastcancersDown-StagingBRCAGenePrecisionMedicinePaclitaxelInvasiveBreastCancerRadiotherapyBreastTomosynthesisCalcificationsCytotoxicBreastCancerMastectomyOligometastasesBOCAApoptosisBI-RADSLymphNodeStatusBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PalpationBevacizumabER-TumorGradeFibroadenomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMastodyniaPalbociclibHormoneReceptorStatusCDK4/6InhibitorsAntibodyTherapyCMFChemotherapyCystWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.GermlineMutationKi-67RateCapecitabine5-FluorouracilAdjuvantTherapyLymphoscintigraphyCAM1 in 8womenAngiogenesisCheckpointInhibitorProgestin

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Chemotherapy
  2. Alopecia
  3. Multimodality Therapy
  4. Dose Dense Therapy
  5. Hormone Replacement Therapy
  6. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  7. Triple Positive Breast Cancer
  8. Co-survivor
  9. Self-examination
  10. Women ages 40+ should have a clinical breast exam at least yearly
  11. Biopsy
  12. ER+
  13. Neoplasm
  14. mTOR Inhibitors
  15. EGFR (epidermal growth factor receptor)
  16. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  17. Tyrosine-Kinase Inhibitor
  18. Guaranteed Renewable Insurance
  19. Herceptin
  20. Multifocal Tumors
  21. Metastasis
  22. PARP Inhibitors
  23. Triple Negative Breast Cancer
  24. Methotrexate
  25. Neoadjuvant Therapy
  26. Aromatase Inhibitors
  27. Advocacy
  28. AC Chemotherapy
  29. HER-2
  30. Node Positive
  31. Flow Cytometry
  32. Brachytherapy
  33. Antiemetic
  34. Phyllodes Tumor
  35. Doxorubicin
  36. Raloxifene
  37. Intraductal Papilloma
  38. MRI
  39. LCIS
  40. In-situ Carcinoma
  41. Bilateral Prophylactic Mastectomy
  42. Pathologic Response
  43. Ayurveda
  44. SERM
  45. Genetic Predisposition
  46. Lapatinib
  47. Genomic Testing
  48. Gail Model
  49. Lumpectomy
  50. Excisional Biopsy
  51. Genetic Counseling
  52. Morphea
  53. Node Negative
  54. Cyclophosphamide
  55. Staging
  56. FISH
  57. Docetaxel
  58. Cytostatic
  59. Estrogen
  60. Gene Mutation
  61. PI3 Kinase Inhibitors
  62. Ovarian Suppression
  63. Tamoxifen
  64. Relapse
  65. RAD
  66. Immunotherapy
  67. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  68. Paget Disease
  69. Cachexia
  70. Kappa Epsilon
  71. Absolute Risk
  72. Adenocarcinoma
  73. Megestrol Acetate
  74. Axillary Sampling
  75. Estradiol
  76. Anastrozole
  77. Chemoprevention
  78. Dimpling
  79. Family History
  80. Lump
  81. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  82. Definitive Surgery
  83. ECOG Score
  84. Physical activity may reduce the risk of breast cancers
  85. Down-Staging
  86. BRCA Gene
  87. Precision Medicine
  88. Paclitaxel
  89. Invasive Breast Cancer
  90. Radiotherapy
  91. Breast Tomosynthesis
  92. Calcifications
  93. Cytotoxic
  94. Breast Cancer
  95. Mastectomy
  96. Oligometastases
  97. BOCA
  98. Apoptosis
  99. BI-RADS
  100. Lymph Node Status
  101. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  102. Palpation
  103. Bevacizumab
  104. ER-
  105. Tumor Grade
  106. Fibroadenoma
  107. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  108. Mastodynia
  109. Palbociclib
  110. Hormone Receptor Status
  111. CDK4/6 Inhibitors
  112. Antibody Therapy
  113. CMF Chemotherapy
  114. Cyst
  115. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  116. Germline Mutation
  117. Ki-67 Rate
  118. Capecitabine
  119. 5-Fluorouracil
  120. Adjuvant Therapy
  121. Lymphoscintigraphy
  122. CAM
  123. 1 in 8 women
  124. Angiogenesis
  125. Checkpoint Inhibitor
  126. Progestin